Open AccessDescriptions of Benefits and Risks in Consent Forms for Phase 1 Oncology Trials
Author(s) -
Sam Horng,
Ezekiel J. Emanuel,
Benjamin S. Wilfond,
Jonathan E. Rackoff,
Karen Martz,
Christine Grady
Publication year - 2002
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmsa021182
Subject(s) - medicine , seriousness , informed consent , clinical trial , alternative medicine , cancer , family medicine , intensive care medicine , pathology , law , political science
Ethicists have suggested that written consent forms encourage participants in phase 1 cancer trials to expect benefit from the experimental agent and to overlook serious risks.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom